DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Robson ME, Im S-A, Senkus E. et al.
OlympiAD: Phase III trial of olaparib monotherapy versus chemotherapy for patients (pts) with HER2-negative metastatic breast cancer (mBC) and a germline BRCA mutation (gBRCAm).
J Clin Oncol 2017;
35 (Suppl.) Abstr. LBA4
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.